We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Drugmakers Urge More EU-U.S. Collaboration on Approvals, Inspections
Generic Drugmakers Urge More EU-U.S. Collaboration on Approvals, Inspections
Generic drugmakers in the U.S. and EU are calling on regulators to create uniform approval pathways for biosimilars and generic medicines, saying standardization would lower drug costs and eliminate the need for duplicate clinical trials for the same product.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor